Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003538 · ClinicalTrials.gov registry record · NA
Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
A NA study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Completed
- Registry status
- NA
- Development phase
NCT00003538: Completed NA study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
NCT00003538 is a NA study that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003538, a NA study, has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
RATIONALE: Bone marrow transplantation may be able to replace immune cells that were destroyed by chemotherapy or radiation therapy used to kill tumor cells. Sometimes the transplanted cells can make an immune response against the body's normal tissues. Stem cells that have been treated in the laboratory to remove lymphocytes may prevent this from happening. PURPOSE: Clinical trial to prevent graft-versus-host disease in patients undergoing bone marrow transplantation.
Interventions
- PROCEDURE allogeneic bone marrow transplantation
- BIOLOGICAL graft versus host disease prophylaxis/therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 1997-03 |
| Est. Completion | 2004-05 |
| Phase | NA |
What the finished NCT00003538 record still lists
NCT00003538 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which allogeneic bone marrow transplantation is the first listed.
NCT00003538 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003538 about?
NCT00003538 is a clinical study titled "Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation". RATIONALE: Bone marrow transplantation may be able to replace immune cells that were destroyed by chemotherapy or radiation therapy used to kill tumor cells. Sometimes the transplanted cells can make an immune response against the body's normal tissues. Stem cells that have been treated in the labor...
What is the current status of trial NCT00003538?
This trial is currently completed. It is a NA study. The study started on 1997-03. Estimated completion is 2004-05.
What interventions are being tested in trial NCT00003538?
The interventions under investigation include: allogeneic bone marrow transplantation (PROCEDURE), graft versus host disease prophylaxis/therapy (BIOLOGICAL).
Who is sponsoring clinical trial NCT00003538?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia